Anxiously waiting to finally get your COVID-19 vaccine shot? Well, you and your loved ones might be getting your shots sooner than you think. Five Metro Manila local government units (LGUs) are scheduled to receive a total of 15,000 Sputnik V vaccine doses today.
The DOH will be distributing today the 15,000 @sputnikvaccine doses to Muntinlupa, Taguig, Parañaque, Makati, and Manila. Each city is allocated 3,000 ampules. | @maricarcincoINQ
Due to logistical concerns, the first batch of the Russian vaccine manufactured by the Gamaleya Research Institute arrived on May 1 instead of the supposed April 29 schedule. Despite the hiccup, the LGU recipients—namely Muntinlupa, Taguig, Parañaque, Makati and Manila—are finally going to receive 3,000 ampoules each for the initial rollout.
Health undersecretary Maria Rosario Vergeire said in a press briefing held today, May 3, that the chosen vaccination sites per city are as follows:
Ospital ng Muntinlupa and Asian Hospital and Medical Center in Muntinlupa
Lakeshore mega-complex facility in Taguig
Ayala Malls Manila Bay in Parañaque
Makati Coliseum in Makati
Sta. Ana Hospital and Ospital ng Maynila in Manila
For those who will be receiving the doses, the Department of Health has prepared an information sheet about Sputnik V which includes the vaccine’s efficacy and possible adverse effects. So if you do experience effects such as hyperthermia (characterized by high-body temperature) and muscle pain, don’t panic.
KNOW YOUR COVID-19 VACCINE: GAMALEYA SPUTNIK V Data as of April 19, 2021
Information you need to know about the Gamaleya Sputnik V COVID-19 vaccine:
In case you’re wondering whether it’s still “safe” to get the vaccine because the Brazilian Health Regulatory Agency (Anvisa) has denied import for it due to safety concerns, the Gamaleya Research Institute has claimed that the allegations “have no scientific grounds.”
In a letter sent to Anvisa on March 26, Gamaleya Institute confirms that quality controls ensure that no RCA is present in Sputnik V. pic.twitter.com/OOlOdysOsK
“Recent inaccurate and misleading comments by Brazilian regulator Anvisa alleged detection of replicated adenovirus (RCA), a weakened viral particle that does not even cause a common cold, in Sputnik V. Gamaleya Institute confirms that no RCA was detected in any of the batches of the Sputnik V vaccine,” wrote the institute in a statement.
While the debacle has put a lot of people on the fence, what we can be sure of is how we’ll be eagerly awaiting more data on one of the government’s vaccine picks from this phase.